Kae Jack Tay
@kaejacktay
Urologic Oncologist | Director of Urologic Oncology, Singapore General Hospital | All views are my own
ID: 2863889521
19-10-2014 02:01:29
90 Tweet
242 Followers
167 Following
Dr Michael Brown from the US FDA outlines the pathway for device approval for Prostate Cancer Focal Therapy. There, rightly so, is a difference between approval for “prostate ablation” vs. “prostate cancer management”. One is a technique, the other is a strategy. Focal Therapy Society